Table_1_The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai “Peritoneal Dialysis First Policy”.DOCX by Pornpen Sangthawan (13952118)

“…Objective<p>Universal health coverage can decrease the magnitude of the individual patient's financial burden of chronic kidney disease (CKD), but the residual financial hardship from the patients' perspective has not been well-studied in low and middle-income countries (LMICs). …”

Global burden of maternal and congenital syphilis and associated adverse birth outcomes—Estimates for 2016 and progress since 2012 by Eline L. Korenromp (157311)

“…To assess progress towards the goal of <50 CS cases per 100,000 live births, we generated regional and global estimates of maternal and congenital syphilis for 2016 and updated the 2012 estimates.…”

Results of experiment 3&4—Flanker experiments with predictable and unpredictable timing. by Klaas Bombeke (3927152)

“…<p>(A)(B) Mean reaction times per SOA condition (irrelevant-first, simultaneous and relevant-first in experiment 1, (A); irrelevant-first in experiment 2, (B)) for current congruent (dark grey) and incongruent (light grey) trials as a function of the congruency level of the previous trial in the Flanker experiments (error bars represent 1 standard deviation around the mean). …”

Interval-discrimination sensitivity and response bias. by Jean Mary Zarate (247129)

“…<p>(A) Left: Mean ± SEM <i>d′</i> values of musicians and non-musicians across all timbres at each interval-difference. …”

Table_4_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.xlsx by Victoria Sun (11195334)

Image_1_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.pdf by Victoria Sun (11195334)

Image_4_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.pdf by Victoria Sun (11195334)

Image_5_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.pdf by Victoria Sun (11195334)

Table_2_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.xlsx by Victoria Sun (11195334)

Image_3_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.pdf by Victoria Sun (11195334)

Table_3_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.xlsx by Victoria Sun (11195334)

Table_1_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.xlsx by Victoria Sun (11195334)

Image_2_The Metabolic Landscape of Thymic T Cell Development In Vivo and In Vitro.pdf by Victoria Sun (11195334)

Modulation of performance during learning. by Daniel Ramandi (10047543)

Effect of microglia depletion on cell viability in the retinal explants. by Rosa M. Ferrer-Martín (623505)

QRT-PCR for 27-hydroxylase and ABCA1 message in NS398-treated THP-1 cells exposed to prostaglandins by Edwin SL Chan (28334)

“…THP-1 human monocytes were exposed to the following conditions represented by the six bars (from left to right): (1) RPMI 1640, (2) NS398 (50 μM), (3) PGE(0.1 μM) + NS398 (50 μM), (4) PGE(0.1 μM) + NS398 (50 μM), (5) PGE(0.1 μM) + PGE(0.1 μM) + NS398 (50 μM), and (6) PGD(14 μM) + NS398 (50 μM) (all 18-hour exposures). …”

Reduced CFTR and CREB expression in human azoospermia testes. by Wen Ming Xu (221689)

“…Statistic data are shown as mean±SEM.</p>…”

Development of EMT and ER-stress in SW480-shZEB1 and SW480-control cells under conditions of hypoxia and reoxygenation. by Evelyn Zeindl-Eberhart (517804)

Incidence of anterior segment neovascularization during intravitreal treatment for macular edema secondary to central retinal vein occlusion by Luiz Filipe Adami Lucatto (5760572)

“…Results: ASN developed in 8 (22.86%) eyes, including 5 (62.50%) eyes in the sham group and 3 (37.50%) eyes in the IVTA group, during 12 months of fol low-up (p=0.009). …”

Knockdown of miR-214 inhibits tumor growth in nude mice: <i>in vivo</i> functional studies. by Zi-Chen Zhang (511377)